Progyny, Inc. Ratios | P/E, ROE & Valuation

On the Key Ratios page for Progyny, Inc. (PGNY), the latest P/E of 27.1 frames valuation, while ROE 15.98% and ROIC 15.32% indicates profitability and capital efficiency. Together with the current ratio of 2.14 and debt-to-equity 0.06, these signals help you judge whether valuation is supported by fundamentals across the historical rows.

Financial Performance Ratios

PGNY Historical Per Share Metrics

9 years
Metric (FY)TTM20242023202220212020201920182017
Revenue per Share$16.77$12.76$11.46$8.54$5.62$4.02$2.75$1.29$8.54
Net Income per Share$1.01$0.59$0.65$0.33$0.74$0.54$-0.10$0.01$-2.19
Operating Cash Flow per Share$3.16$1.96$1.99$0.87$0.29$0.42$-0.02$0.03$-1.66
Free Cash Flow per Share$2.79$1.90$1.95$0.84$0.27$0.41$-0.05$0.02$-1.77
Cash per Share$3.03$2.49$3.91$2.05$1.34$1.28$0.96$0.00$0.82
Book Value per Share$5.80$4.61$5.82$4.09$2.83$1.95$1.37$0.14$1.88
Tangible Book Value per Share$5.47$4.43$5.70$3.96$2.69$1.79$1.20$-0.06$-1.15
Interest Debt per Share$0.35$0.21$0.20$0.08$0.10$0.11$0.00$0.00$0.91
CAPEX per Share$0.37$0.06$0.04$0.04$0.02$0.01$0.04$0.01$0.11

PGNY Historical Valuation Ratios

9 years
Metric (FY)TTM20242023202220212020201920182017
Price to Earnings (P/E)27.129.0456.9594.668.2278.21-267.721966.86-7.28
Price to Book (P/B)4.533.746.387.6217.8221.7720.08116.898.48
Price to Sales (P/S)1.571.353.253.658.9610.549.9912.331.87
Enterprise Value to EBITDA15.2221.2753.59110.64130.9348.45187.44-828.69-9.65
EV to Sales1.481.233.173.518.810.369.6412.341.88
EV to Operating Cash Flow7.828.0118.334.32169.1398.69-1443.07572.28-9.63
EV to Free Cash Flow8.878.2618.6635.77184.19101.6-493.02768-9.04
Enterprise Value$1.93B$1.44B$3.45B$2.76B$4.40B$3.57B$2.21B$1.30B$91.20M

PGNY Historical Profitability Ratios

9 years
Metric (FY)TTM20242023202220212020201920182017
Return on Equity (ROE)15.98%12.87%11.21%8.05%26.12%27.83%-7.50%5.94%-116.48%
Return on Invested Capital (ROIC)15.32%9.92%9.49%7.51%25.06%25.19%24.41%-22.52%-53.03%
Return on Tangible Assets11.39%9.21%8.33%5.72%19.03%19.29%-6.29%2.58%-70.20%
Earnings Yield3.83%3.44%1.76%1.06%1.47%1.28%-0.37%0.05%-13.73%
Free Cash Flow Yield10.59%11.01%5.24%2.69%0.53%0.97%-0.20%0.13%-11.12%
Dividend Yield0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

PGNY Historical Liquidity & Financial Strength

9 years
Metric (FY)TTM20242023202220212020201920182017
Current Ratio2.142.83.442.722.622.453.660.810.94
Interest Coverage000000480.2200
Income Quality2.43.33.042.650.40.780.183.440.76
Debt to Equity0.060.050.040.020.030.0600.020.49
Debt to Assets3.77%3.17%2.56%1.42%2.42%3.76%0.00%0.61%14.84%
Net Debt to EBITDA-0.99-2.12-1.21-4.51-2.46-5.93-6.81-0.08-0.05

PGNY Historical Efficiency Ratios

9 years
Metric (FY)TTM20242023202220212020201920182017
Receivables Turnover5.094.964.53.283.724.564.884.524.27
Payables Turnover6.59.616.785.676.336.329.55.528.03
Inventory Turnover000000000
Days Sales Outstanding71.773.5981.1111.3598.180.0874.7880.7785.44
Days Payables Outstanding56.1337.9853.8764.3857.6957.838.4266.1445.47
Days of Inventory on Hand000000000

PGNY Historical Market Metrics

9 years
Metric (FY)TTM20242023202220212020201920182017
Enterprise Value to EBITDA15.2221.2753.59110.64130.9348.45187.44-828.69-9.65
Market Cap$2.06B$1.58B$3.53B$2.87B$4.49B$3.63B$2.29B$1.30B$90.70M
Enterprise Value$1.93B$1.44B$3.45B$2.76B$4.40B$3.57B$2.21B$1.30B$91.20M
Dividend Yield0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Payout Ratio0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions

How does Progyny, Inc.’s P/E ratio compare with its history?

On this page, PGNY's current P/E is 27.1, compared with a multi-year average around 331.6. A lower P/E versus its own history is a calculated gap versus that average—not a conclusion that the stock is cheap. Pair it with profitability and earnings quality in the table (for example ROE/ROIC) to see whether the multiple moved with earnings.

What is Progyny, Inc. market cap?

Market cap is the market value of a company's equity and is commonly calculated as share price multiplied by shares outstanding. The latest market cap shown in the table is $2.06B. Pair market cap with valuation multiples (P/E, P/B, P/S) so you can evaluate whether size also corresponds with "quality" and profitability. For a wider view across stocks, you can also use the stock screener.

How does Progyny, Inc.’s P/E compare with its industry?

There is no P/E Tickerplace rates as good. Compare the P/E on this page with Progyny, Inc.'s own historical range (in the table) and with peers via the Screener and Compare tools. A higher or lower multiple versus peers is a calculated gap, not a recommendation.

How does Progyny, Inc. compare to its competitors in key financial ratios?

The fastest way to compare Progyny, Inc. with competitors is to use the built-in "Peers Comparison" section on this page and the Compare tool. Focus on a small set of ratios that work together: P/E for valuation, ROE/ROIC for profitability and capital efficiency, current ratio and interest coverage for liquidity and solvency, and debt-to-equity for leverage risk. When you see Progyny, Inc. outperform peers on profitability while keeping valuation and leverage reasonable, it often signals stronger fundamentals.

What do Progyny, Inc.'s liquidity and leverage ratios show?

Liquidity and leverage figures on this page are published ratios, not a verdict that Progyny, Inc. is financially strong. Current ratio is about 2.14, which is above 1.0 and can indicate more comfortable short-term liquidity. Interest coverage is about 0.00, implying less buffer for servicing interest costs. Debt-to-equity is about 0.06, suggesting leverage is more moderate relative to a high-debt profile. Pair them with ROE/ROIC and cash-flow rows in the table. Tickerplace does not rate the company as a good or poor investment.

What do Progyny, Inc.'s financial ratios say about its future growth?

Ratios are a way to see what the business is likely to sustain. Look for upward trends in profitability metrics (ROE and ROIC), improving earnings/cash-flow backed measures, and stable or strengthening liquidity. If Progyny, Inc. is sustaining strong returns (for example ROE at 15.98% and ROIC at 15.32%) while debt levels and interest coverage remain manageable, growth expectations may be more credible. If valuation multiples expand while returns weaken, the market may be pricing optimistic growth ahead of results.